Recent News

• 05.12.2025 - Arcturus Therapeutics First Quarter 2025 Earnings Call
• 04.22.2025 - Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
• 04.22.2025 - Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
• 04.16.2025 - William Blair Discussion with Arcturus on Upcoming ARCT-032 Phase II Data | Fireside Chat
• 04.11.2025 - Cantor Hosting
• 04.10.2025 - Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
• 04.10.2025 - Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
• 03.12.2025 - Leerink's Global Healthcare Conference 2025| Fireside Chat
• 03.06.2025 - Arcturus Therapeutics Fourth Quarter and Full Year 2024 Earnings Call
• 03.06.2025 - Arcturus Therapeutics Fourth Quarter and Full Year 2024 Earnings Call

Recent Filings

• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 8-K Current report